Piccirillo Francesco, Watanabe Mikiko, Di Sciascio Germano
Unit of Cardiovascular Sciences, Campus Bio-Medico University of Rome, Rome, Italy.
Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Rome, Italy.
Cardiovasc Pathol. 2021 Sep-Oct;54:107362. doi: 10.1016/j.carpath.2021.107362. Epub 2021 Jun 27.
Although it has been recognized for almost two centuries, myocarditis is still a challenging diagnosis due to the wide heterogeneity of its clinical manifestations and evolution. Moreover, the diagnostic gold standard, endomyocardial biopsy (EMB), is infrequently used, making hard to determine the exact incidence of myocarditis. Clinical presentation includes a wide range of symptoms, ranging from asymptomatic or subclinical disease with mild dyspnea and chest pain to sudden death, due to cardiogenic shock or malignant ventricular arrhythmias. Equally, the evolution of myocarditis largely varies: albeit short-term prognosis is usually good, with complete or partial recovery, dilated cardiomyopathy with chronic heart failure is the major long-term consequence of myocarditis, developing often several years after the acute onset. This narrative review aims to summarize the current knowledge about myocarditis, with a particular attention to predictors of short- and long-term prognosis, in order to provide a rational and practical approach to the diagnosis, evaluation and treatment of suspected myocarditis.
尽管心肌炎已被认识近两个世纪,但由于其临床表现和病程的广泛异质性,它仍然是一个具有挑战性的诊断。此外,诊断金标准心内膜心肌活检(EMB)很少使用,这使得难以确定心肌炎的确切发病率。临床表现包括广泛的症状,从无症状或亚临床疾病伴轻度呼吸困难和胸痛到因心源性休克或恶性室性心律失常导致的猝死。同样,心肌炎的病程差异很大:尽管短期预后通常良好,可完全或部分恢复,但扩张型心肌病伴慢性心力衰竭是心肌炎的主要长期后果,通常在急性发作后数年出现。本叙述性综述旨在总结目前关于心肌炎的知识,特别关注短期和长期预后的预测因素,以便为疑似心肌炎的诊断、评估和治疗提供合理实用的方法。